MCPyV is integrated into the genome of approximately 80% of MCC cases, where viral oncoproteins, particularly the large T antigen, interfere with tumor suppressor proteins like p53 and RB1, driving tumorigenesis [25, 26]. The gene discussed is RB1; the disease is Merkel cell skin cancer.